Table 2.
Results of laboratory testing
| Test | Result (reference range) |
|---|---|
| Basic laboratory panel | |
| Complete blood count | All values within normal range |
| Complete metabolic panel | All values within normal range |
| Lipid panel | All values within normal range |
| Hypercoagulability panel | |
| PT | 11.4 (9.4–12.5) s |
| INR | 1 (0.8–1.1) |
| PTT | 30.9 (25.1–36.5) s |
| Anticardiolipin IgG (GPL units) | 5.5 (0.0–11.0) |
| Anticardiolipin IgM (MPL units) | 8.5 (0.0–12.0) |
| Anti-ß2 glycoprotein 1 IgG | 0.5 (0.0–7.9) |
| Anti-ß2 glycoprotein 1 IgM | 2.0 (0.0–12.9) |
| Tissue thromboplastic inhibition test | 1.1 (0.0–1.4) s |
| dRVVT | 36.5 (28.0–42.0) s |
| Protein C functional | 92 (83–168) % |
| Protein S functional | 77 (66–143) % |
| SARS-CoV-2 antibodies, nucleocapsid | Reactive |
IgG, immunoglobulin G; IgM, immunoglobulin M; MPL unit, cardio-lipin-binding activity of 1 µg/mLl of affinity-purified IgM; GPL unit, cardiolipin-binding activity of 1 µg/mL of affinity-purified IgG; dRVVT, dilute Russell viper venom time; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.